Is CGLO or JNJ a better dividend investment in 2026?

CGLO currently yields 172413.79% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: CGLO offers higher current income.

What is the dividend yield difference between CGLO and JNJ?

CGLO has a forward dividend yield of 172413.79% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 172411.66 percentage points.

Home › Compare › CGLO vs JNJ

CGLO vs JNJ: Dividend Comparison 2026

CGLO yields 172413.79% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CGLO wins by $1.114736613836205e+29M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CGLO

● Live price

172413.79%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.114736613836205e+29M

Annual income

$111,346,620,703,113,960,000,000,000,000,000,000.00

Full CGLO calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — CGLO vs JNJ

📍 CGLO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CGLO	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CGLO + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CGLO pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CGLO

Annual income on $10K today (after 15% tax)

$14,655,172.41/yr

After 10yr DRIP, annual income (after tax)

$94,644,627,597,646,870,000,000,000,000,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, CGLO beats the other by $94,644,627,597,646,870,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CGLO + JNJ for your $10,000?

CGLO: 50%JNJ: 50%

100% JNJ50/50100% CGLO

Portfolio after 10yr

$5.573683069181025e+28M

Annual income

$55,673,310,351,556,980,000,000,000,000,000,000.00/yr

Blended yield

99.89%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CGLO

No analyst data

Altman Z

-77.2

Piotroski

3/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CGLO buys

JNJ buys

No recent congressional trades found for CGLO or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCGLOJNJ

Forward yield	172413.79% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$1.114736613836205e+29M	$30.3K ✓
Annual income after 10y	$111,346,620,703,113,960,000,000,000,000,000,000.00 ✓	$4,689.40
Total dividends collected	$1.114653420297989e+29M	$15.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CGLO vs JNJ ($10,000, DRIP)

Year	CGLO Portfolio	CGLO Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$17,252,079	$17,241,379.31	$10,592	$272.30	+$17.24M → CGLO
2	$27,817,491,807	$27,799,032,082.41	$11,289	$357.73	+$27817.48M → CGLO
3	$41,920,927,936,744	$41,891,163,220,510.10	$12,123	$472.89	+$41920927.92M → CGLO
4	$59,044,794,137,820,630	$58,999,938,744,928,320.00	$13,141	$629.86	+$59044794137.81M → CGLO
5	$77,726,955,074,684,580,000	$77,663,777,144,957,120,000.00	$14,408	$846.81	+$77726955074684.56M → CGLO
6	$95,631,865,672,271,440,000,000	$95,548,697,830,341,520,000,000.00	$16,021	$1,151.60	+$95631865672271440.00M → CGLO
7	$109,970,515,820,033,700,000,000,000	$109,868,189,723,764,360,000,000,000.00	$18,122	$1,588.22	+$109970515820033703936.00M → CGLO
8	$118,193,720,765,446,910,000,000,000,000	$118,076,052,313,519,480,000,000,000,000.00	$20,930	$2,228.20	+$1.1819372076544692e+23M → CGLO
9	$118,729,607,950,025,770,000,000,000,000,000	$118,603,140,668,806,730,000,000,000,000,000.00	$24,792	$3,191.91	+$1.1872960795002577e+26M → CGLO
10	$111,473,661,383,620,510,000,000,000,000,000,000	$111,346,620,703,113,960,000,000,000,000,000,000.00	$30,274	$4,689.40	+$1.114736613836205e+29M → CGLO

CGLO vs JNJ: Complete Analysis 2026

CGLO — Stock

Coro Global Inc. develops and commercializes financial technology products in the United States and the District of Columbia. It offers Coro, a mobile application that allows customers to send, receive, and exchange the United States dollars and gold; and Financial Crime Risk Management, an integrated anti-money laundering/know your customer onboarding and transaction monitoring solution that provides an integrated compliance solution for compliance departments. The company was formerly known as Hash Labs Inc. and changed its name to Coro Global Inc. in January 2020. Coro Global Inc. was founded in 2005 and is based in Miami, Florida.

Full CGLO Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this CGLO vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CGLO vs SCHD CGLO vs JEPI CGLO vs O CGLO vs KO CGLO vs MAIN CGLO vs ABBV CGLO vs MRK CGLO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.